跳至主要内容
临床试验/NCT02149316
NCT02149316已完成不适用

Cardioprotective Effects of Remote Ischemic Preconditioning With Postconditioning of the Recipient on Donor Heart in Heart Transplantation Surgery

Chinese Academy of Medical Sciences, Fuwai Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
serum cardiac troponin I (cTnI)

研究概览

简要总结

The purpose of this study is to determine whether remote ischemic preconditioning with postconditioning (RIPC+RIPostC) reduces myocardial injury and improves clinical outcomes in heart transplantation surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
14 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • scheduled for elective orthotopic heart transplantation surgery

排除标准

  • peripheral vascular disease affecting the upper arms
  • mechanical circulatory support before surgery
  • taking the antidiabetic sulphonylurea, glibenclamide
  • cold ischemic time of donor heart > 12 hours
  • repeated heart surgery

结局指标

主要结局

serum cardiac troponin I (cTnI)

时间窗: within 72 hours after aortic declamping

次要结局

  • plasma microRNA-133b (miR-133b)(within 72 hours after aortic declamping)
  • plasma microRNA-208a (miR-208a)(within 72 hours after aortic declamping)

研究者

发起方
Chinese Academy of Medical Sciences, Fuwai Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Guyan Wang

The Chief of Infection-Control Department

Chinese Academy of Medical Sciences, Fuwai Hospital

研究点 (2)

Loading locations...

相似试验